Literature DB >> 9602213

Methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis.

R Q Cron1, D D Sherry, C A Wallace.   

Abstract

Low-dose methotrexate, widely used for juvenile rheumatoid arthritis, has been reported to cause pneumonitis in adults. We report on methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis. Physicians should be aware of this rare complication.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9602213     DOI： 10.1016/s0022-3476(98)70331-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  6 in total

Review 1.  Hypersensitivity pneumonitis in children: clinical features, diagnosis, and treatment.

Authors:  Purnima Venkatesh; Laurianne Wild
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 2.  Juvenile rheumatoid arthritis: therapeutic perspectives.

Authors:  Ian C Chikanza
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

3.  Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria.

Authors:  Tim Niehues; Gerd Horneff; Hartmut Michels; Michaela Sailer Höck; Lothar Schuchmann
Journal:  Rheumatol Int       Date:  2005-02-02       Impact factor: 2.631

Review 4.  Recommendations for the use of methotrexate in juvenile idiopathic arthritis.

Authors:  Tim Niehues; Petra Lankisch
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

5.  Folate usage in MTX-treated juvenile idiopathic arthritis (JIA) patients is inconsistent and highly variable.

Authors:  Gil Amarilyo; Gil Amarlilyo; Ornella J Rullo; Deborah K McCurdy; Jennifer M P Woo; Daniel E Furst
Journal:  Rheumatol Int       Date:  2013-02-12       Impact factor: 2.631

6.  Treatment of juvenile rheumatoid arthritis.

Authors:  Kwang Nam Kim
Journal:  Korean J Pediatr       Date:  2010-11-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.